166 related articles for article (PubMed ID: 34554113)
21. [Hepatitis C in a psychiatric setting: A forgotten reservoir?].
Rolland B; Bailly F; Cutarella C; Drevon O; Carrieri P; Darque A; Hallouche N; Maptue N; Pol S; Llorca PM; Lang JP
Encephale; 2021 Apr; 47(2):181-184. PubMed ID: 32473777
[TBL] [Abstract][Full Text] [Related]
22. Is global elimination of HCV realistic?
Calvaruso V; Petta S; Craxì A
Liver Int; 2018 Feb; 38 Suppl 1():40-46. PubMed ID: 29427499
[TBL] [Abstract][Full Text] [Related]
23. Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study.
Chen Q; Ayer T; Bethea E; Kanwal F; Wang X; Roberts M; Zhuo Y; Fagiuoli S; Petersen J; Chhatwal J
BMJ Open; 2019 Jun; 9(6):e026726. PubMed ID: 31189677
[TBL] [Abstract][Full Text] [Related]
24. Progress towards hepatitis C virus elimination in high-income countries: An updated analysis.
Gamkrelidze I; Pawlotsky JM; Lazarus JV; Feld JJ; Zeuzem S; Bao Y; Gabriela Pires Dos Santos A; Sanchez Gonzalez Y; Razavi H
Liver Int; 2021 Mar; 41(3):456-463. PubMed ID: 33389788
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C Elimination in Moldova Is Feasible and Cost-Saving: A Modeling Study.
Aaron A; Zhong H; Hiebert L; Zhuo Y; Adee M; Paraschiv A; Stratulat S; Ward JW; Chhatwal J
J Infect Dis; 2023 Sep; 228(Suppl 3):S189-S197. PubMed ID: 37703345
[TBL] [Abstract][Full Text] [Related]
27. Innovations in Hepatitis C Screening and Treatment.
Patel AA; Bui A; Prohl E; Bhattacharya D; Wang S; Branch AD; Perumalswami PV
Hepatol Commun; 2021 Mar; 5(3):371-386. PubMed ID: 33681673
[TBL] [Abstract][Full Text] [Related]
28. Is elimination of hepatitis C virus realistic by 2030: Eastern Europe.
Isakov V; Tsyrkunov V; Nikityuk D
Liver Int; 2021 Jun; 41 Suppl 1():50-55. PubMed ID: 34155800
[TBL] [Abstract][Full Text] [Related]
29. Accelerating the elimination of hepatitis C in Kuwait: An expert opinion.
Hasan F; Alfadhli A; Al-Gharabally A; Alkhaldi M; Colombo M; Lazarus JV
World J Gastroenterol; 2020 Aug; 26(30):4415-4427. PubMed ID: 32874054
[TBL] [Abstract][Full Text] [Related]
30. A micro-elimination approach to addressing hepatitis C in Turkey.
Idilman R; Razavi H; Robbins-Scott S; Akarca US; Örmeci N; Kaymakoglu S; Aygen B; Tozun N; Güner R; Bodur H; Lazarus JV
BMC Health Serv Res; 2020 Mar; 20(1):249. PubMed ID: 32209103
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach.
Benzaken AS; Girade R; Catapan E; Pereira GFM; Almeida EC; Vivaldini S; Fernandes N; Razavi H; Schmelzer J; Ferraz ML; Ferreira PRA; Pessoa MG; Martinelli A; Souto FJD; Walsh N; Mendes-Correa MC
Braz J Infect Dis; 2019; 23(3):182-190. PubMed ID: 31145876
[TBL] [Abstract][Full Text] [Related]
32. Liver health events: an indigenous community-led model to enhance HCV screening and linkage to care.
Pandey M; Konrad S; Reed N; Ahenakew V; Isbister P; Isbister T; Gallagher L; Campbell T; Skinner S
Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34125199
[TBL] [Abstract][Full Text] [Related]
33. Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era.
Cortesi PA; Barca R; Giudicatti G; Mossini S; Ciaccio A; Iannazzo S; Micale M; Cesana G; Mantovani LG
Aliment Pharmacol Ther; 2019 May; 49(9):1126-1133. PubMed ID: 30843268
[TBL] [Abstract][Full Text] [Related]
34. Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.
Gountas I; Sypsa V; Papatheodoridis G; Souliotis G; Razavi H; Hatzakis A
J Gastroenterol Hepatol; 2017 Feb; 32(2):466-472. PubMed ID: 27403912
[TBL] [Abstract][Full Text] [Related]
35. Confirmation of guideline-defined hepatitis C screening strategies within the 'Check-Up35+' examination in the primary care setting.
Petroff D; Wolffram I; Bätz O; Jedrysiak K; Kramer J; Berg T; Wiegand J
Liver Int; 2023 Apr; 43(4):785-793. PubMed ID: 36621849
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation.
Zhong H; Aaron A; Hiebert L; Serumondo J; Zhuo Y; Adee M; Rwibasira GN; Ward JW; Chhatwal J
Value Health; 2024 Jul; 27(7):918-925. PubMed ID: 38492923
[TBL] [Abstract][Full Text] [Related]
37. Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study.
Olafsson S; Fridriksdottir RH; Love TJ; Tyrfingsson T; Runarsdottir V; Hansdottir I; Bergmann OM; Björnsson ES; Johannsson B; Sigurdardottir B; Löve A; Baldvinsdottir GE; Hernandez UB; Gudnason T; Heimisdottir M; Hellard M; Gottfredsson M
Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):628-637. PubMed ID: 34171267
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C elimination - Macro-elimination.
Kåberg M; Weiland O
Liver Int; 2020 Feb; 40 Suppl 1():61-66. PubMed ID: 32077600
[TBL] [Abstract][Full Text] [Related]
39. CROI 2018: Highlights of Viral Hepatitis.
Luetkemeyer AF; Wyles DL
Top Antivir Med; 2018 May; 26(1):30-38. PubMed ID: 29727295
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
